VALIANTLABNSEValiant Laboratories LimitedMinimalNeutral
Announced Tue, 26 May · 14:49 IST

Santosh Vora has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹77.90
prior close
₹81.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-0.0+2.7+1.9+2.1-2.0-4.4-5.6-14.3-14.6-20.4
Up moveDown movePending
AI summary

Santosh Shantilal Vora, Promoter of Valiant Laboratories Limited, has filed a disclosure confirming that the Promoter Group (including Persons Acting in Concert) collectively holds 4,07,01,487 equity shares as of March 31, 2026. The disclosure is made under Regulation 31(4) of the SEBI SAST Regulations, which requires promoters to periodically declare their shareholding and encumbrance status. The promoter group has confirmed that no encumbrance has been created or invoked on any of the shares held by them. The largest individual promoter holding is Dhanvallabh Ventures LLP with 2,54,37,500 shares. The filing was submitted to both NSE and BSE on April 6, 2026.

Likely market impact

The confirmation of no encumbrances indicates the promoter group maintains full control and flexibility over their shares. With no pledges or encumbrances, the promoter stake is free from risk of forced dilution, which is a positive signal for minority shareholders.